Sinopharm-led group plans to take private HK-listed TCM in $3.3b deal

Sinopharm-led group plans to take private HK-listed TCM in $3.3b deal

A consortium led by state-owned pharma giant Sinopharm plans to take private China Traditional Chinese Medicine Holdings in a deal that would value the firm at least $3.3 billion, said two people with direct knowledge of the matter.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter